The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations
Open Access
- 1 November 1992
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (32) , 22770-22778
- https://doi.org/10.1016/s0021-9258(18)50014-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Solvent content of protein crystalsPublished by Elsevier ,2006
- Synthesis of C2-symmetric and pseudosymmetric HIV-1 protease inhibitors from D-arabitolBioorganic & Medicinal Chemistry Letters, 1991
- Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 proteaseBiochemistry, 1991
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesNature, 1990
- Structure of Complex of Synthetic HIV-1 Protease with a Substrate-Based Inhibitor at 2.3 Å ResolutionScience, 1989
- Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1Nature, 1989
- Refinement at 1.4 Å resolution of a model of erabutoxin b: treatment of ordered solvent and discrete disorderActa Crystallographica Section A Foundations of Crystallography, 1988
- The use of an imaging proportional counter in macromolecular crystallographyJournal of Applied Crystallography, 1987
- Transformations to optimize the superposition of similar structuresActa Crystallographica Section A, 1979